The Heller School for Social Policy and Management

Andrew Kolodny

Senior Scientist

Andrew Kolodny's photo

Contact

Email: akolodny@brandeis.edu
Office: Heller-Brown Building 261
Phone: 781 736-4542
Brandeis Directory

Expertise

Dr. Andrew Kolodny is the Medical Director of Opioid Policy Research at the Heller School for Social Policy and Management. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics.

EDUCATION AND TRAINING

Columbia University College of Physicians and Surgeons, New York, NY
Fellowship in Public Psychiatry (2003-2004)

Unites States Senate, Washington, DC
Daniel X Freedman Health Policy Fellowship (2003)

Mount Sinai School of Medicine, New York, NY
Internship & Residency in Psychiatry (1999-2003)

Degrees

  • Temple University
    M.D.
  • Queens College, City University of New York
    B.A.

Andrew Kolodny

Senior Scientist

Profile

Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national non profit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City. Dr. Kolodny has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including city-wide buprenorphine programs, naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.

Dr. Kolodny's testimony before for the United States Congress is available here.

Senate Caucus on International Narcotics Control. May 14, 2014
America's Addiction to Opioids: Heroin and Prescription Drug Use

Homeland Security and Governmental Affairs. January 17, 2018
Unintended Consequences: Medicaid and the Opioid Epidemic

Committee on Energy & Commerce, Subcommittee on Health, U.S. House of Representatives. February 28, 2018
Combatting the Opioid Crisis

See the listing of Dr. Kolodny's publications on PubMed
here.

Awards and Honors

  • University of Chicago Leon I. Goldberg Award (2019)

Scholarship

  • Kolodny, Andrew. "Assessment of Excess Mortality Associated With Drug Overdose in Ohio From 2009 to 2018." JAMA Network Open (2021).
  • Kolodny, Andrew. "How FDA Failures Contributed to the Opioid Crisis." AMA Journal of Ethics (2021).
  • Kolodny, Andrew. "Trends in Heroin Treatment Admissions in the United States by Race, Sex, and Age.." JAMA Network Open (2021).
  • Kolodny, Andrew. "Validation of the Opioid Overdose Risk Behavior Scale, version 2 (ORBS-2)." Drug Alcohol Depend 223. 108721 (2021).